Diametric Capital’s Enliven Therapeutics ELVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-29,284	Closed	-$515K	–	401
2024 Q1	$515K	Buy	+29,284	New	+$515K	0.29%	79
2023 Q1	–	Sell	-42,986	Closed	-$703K	–	378
2022 Q4	$703K	Buy	+42,986	New	+$703K	0.34%	108